Gilder Gagnon Howe & Co’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.6M	Sell	235,433 -4,483	-2%	-$355K	0.24%	87
2025 Q4	$18.7M	Sell	239,916 -6,788	-3%	-$458K	0.2%	93
2025 Q3	$14M	Sell	246,704 -82,316	-25%	-$3.71M	0.14%	106
2025 Q2	$14.4M	Buy	329,020 +10,639	+3%	+$366K	0.15%	98
2025 Q1	$8.71M	Sell	318,381 -7,968	-2%	-$290K	0.11%	110
2024 Q4	$13.1M	Buy	326,349 +35,009	+12%	+$1.58M	0.14%	105
2024 Q3	$13.8M	Buy	291,340 +160,611	+123%	+$7.09M	0.17%	108
2024 Q2	$3.9M	Sell	130,729 -2,260	-2%	-$78.2K	0.05%	154
2024 Q1	$5.35M	Buy	+132,989	New	+$4.76M	0.07%	148
2023 Q4	–	Sell	-81,865	Closed	-$1.14M	–	263
2023 Q3	$1.14M	Sell	81,865 -6,867	-8%	-$138K	0.02%	205
2023 Q2	$2.04M	Sell	88,732 -764	-0.9%	-$21.9K	0.03%	198
2023 Q1	$2.65M	Sell	89,496 -690	-0.8%	-$22.3K	0.04%	161
2022 Q4	$2.25M	Buy	90,186 +8,992	+11%	+$240K	0.04%	167
2022 Q3	$1.77M	Sell	81,194 -13,879	-15%	-$366K	0.03%	176
2022 Q2	$1.87M	Sell	95,073 -19,433	-17%	-$454K	0.03%	177
2022 Q1	$4.85M	Sell	114,506 -5,447	-5%	-$230K	0.04%	180
2021 Q4	$7.62M	Sell	119,953 -11,741	-9%	-$684K	0.04%	191
2021 Q3	$7.74M	Buy	131,694 +23,116	+21%	+$1.34M	0.04%	218
2021 Q2	$5.27M	Buy	+108,578	New	+$4.71M	0.03%	252